IP Library Assignment 018862/0211
Patent Assignment
Reel/Frame 018862/0211

Confirmation of Exclusive Patent License

Recorded: 2007-02-06 Pages: 2
Assignor
QUARK BIOTECH INC.
Executed: 2006-09-25
Assignee
PFIZER INC.
235 EAST 42ND STREET, INTELLECTUAL PROPERTY, NEW YORK, NEW YORK, 10017
Covered Properties (2)
Therapeutic Uses of Inhibitors of RTP801
Patent: 7,741,299 →
Application: 11/207,119 →
Publication: US 2006/0217329
Therapeutic Uses of Inhibitors of RTP801
Patent: 8,067,570 →
Application: 11/655,636 →
Publication: US 2010/0272722
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 5, 2005
From: FEINSTEIN, ELENA
To: QUARK BIOTECH,INC.
Reel/Frame 017315/0483 →
Assignment of Assignor's Interest Jan 22, 2007
From: QUARK BIOTECH, INC.
To: ATUGEN AG
Reel/Frame 018824/0290 →
Assignment of Assignor's Interest Mar 12, 2007
From: QUARK BIOTECH, INC.
To: ATUGEN AG
Reel/Frame 019021/0188 →
Assignment of Assignor's Interest Mar 12, 2007
From: FEINSTEIN, ELENA; SKALITER, RAMI
To: QUARK BIOTECH, INC.
Reel/Frame 019029/0430 →
Change of Name Dec 3, 2007
From: QUARK BIOTECH, INC.
To: QUARK PHARMACUTICALS, INC.
Reel/Frame 020206/0703 →
Change of Name Sep 15, 2008
From: ATUGEN AG (AKTIENGESELLSCHAFT)
To: SILENCE THERAPEUTICS AG (AKTIENGESELLSCHAFT)
Reel/Frame 021545/0114 →
Assignment of Assignor's Interest Jan 20, 2010
From: SILENCE THERAPEUTICS AG
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 023823/0012 →
Assignment of Assignor's Interest Jan 20, 2010
From: KAUFMANN, JORG; GIESE, KLAUS
To: SILENCE THERAPEUTICS AG
Reel/Frame 023830/0738 →